This is a renewal application for a set of experiments intended to explore the hypothesis that increases in blood pressure over time depend on increased arterial smooth muscle mass in the walls of resistance vessels. We suggest that these increases in mass are due to """"""""remodeling,"""""""" a general mechanism for adaptation of blood vessels to increased physiological demands. We have found that increases in vascular mass are associated with smooth muscle DNA replication, raising the possibility that the increased DNA content may provide a form of memory leading to further increases in blood pressure via a positive feedback loop. In exploring this hypothesis we have recently learned that vasoactive agents are not themselves sufficient to elicit DNA synthesis in arterial smooth muscle in vivo despite having the ability to induce expression of genes required for DNA synthesis. The experiments in this proposal attempt to determine whether increased DNA content in hypertensive artery walls does predispose to further increases in vascular mass, to identify the additional condition(s) required for entry into DNA synthesis following a vasoactive stimulus, and to separate the roles of the three vessel wall cells, endothelial cells, smooth muscle cells and nerves in the remodeling of hypertensive vessel walls.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL026405-10
Application #
3338598
Study Section
Pathology A Study Section (PTHA)
Project Start
1980-08-01
Project End
1993-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
10
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wang, Xi; Adams, Lawrence D; Pabon, Lil M et al. (2008) RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy. J Mol Cell Cardiol 44:539-50
Mahoney, William M; Schwartz, Stephen M (2005) Defining smooth muscle cells and smooth muscle injury. J Clin Invest 115:221-4
Mulvihill, Eileen R; Jaeger, Jochen; Sengupta, Rimli et al. (2004) Atherosclerotic plaque smooth muscle cells have a distinct phenotype. Arterioscler Thromb Vasc Biol 24:1283-9
Rosenfeld, Michael E; Kauser, Katalin; Martin-McNulty, Baby et al. (2002) Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 164:251-9
Lombardi, D M; Viswanathan, M; Vio, C P et al. (2001) Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron 87:66-74
Rosenfeld, M E; Polinsky, P; Virmani, R et al. (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20:2587-92
Imanishi, T; McBride, J; Ho, Q et al. (2000) Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model. Am J Pathol 156:125-37
Yee, K O; Ikari, Y; Bodary, S et al. (2000) Kistrin inhibits human smooth muscle cell interaction with fibrin. Thromb Res 97:39-50
Yee, K O; Schwartz, S M (1999) Why atherosclerotic vessels narrow: the fibrin hypothesis. Thromb Haemost 82:762-71
Adams, L D; Lemire, J M; Schwartz, S M (1999) A systematic analysis of 40 random genes in cultured vascular smooth muscle subtypes reveals a heterogeneity of gene expression and identifies the tight junction gene zonula occludens 2 as a marker of epithelioid ""pup"" smooth muscle cells and a particip Arterioscler Thromb Vasc Biol 19:2600-8

Showing the most recent 10 out of 31 publications